Amarin Corp PLC (AMRN)
0.7963
+0.01
(+0.64%)
USD |
NASDAQ |
Jul 26, 16:00
0.7963
0.00 (0.00%)
After-Hours: 20:00
Amarin 1 Year Total Returns (Daily): -29.98% for July 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| July 25, 2024 | -29.98% |
| July 24, 2024 | -32.38% |
| July 23, 2024 | -29.88% |
| July 22, 2024 | -29.54% |
| July 19, 2024 | -27.33% |
| July 18, 2024 | -44.76% |
| July 17, 2024 | -40.46% |
| July 16, 2024 | -36.28% |
| July 15, 2024 | -39.44% |
| July 12, 2024 | -36.53% |
| July 11, 2024 | -38.36% |
| July 10, 2024 | -35.17% |
| July 09, 2024 | -38.60% |
| July 08, 2024 | -35.12% |
| July 05, 2024 | -38.11% |
| July 03, 2024 | -41.33% |
| July 02, 2024 | -40.76% |
| July 01, 2024 | -42.35% |
| June 28, 2024 | -38.57% |
| June 27, 2024 | -39.58% |
| June 26, 2024 | -38.21% |
| June 25, 2024 | -36.11% |
| June 24, 2024 | -37.81% |
| June 21, 2024 | -41.01% |
| June 20, 2024 | -40.25% |
| Date | Value |
|---|---|
| June 18, 2024 | -38.65% |
| June 17, 2024 | -36.30% |
| June 14, 2024 | -36.74% |
| June 13, 2024 | -37.09% |
| June 12, 2024 | -36.01% |
| June 11, 2024 | -38.89% |
| June 10, 2024 | -50.16% |
| June 07, 2024 | -47.42% |
| June 06, 2024 | -44.06% |
| June 05, 2024 | -42.90% |
| June 04, 2024 | -45.31% |
| June 03, 2024 | -33.38% |
| May 31, 2024 | -26.07% |
| May 30, 2024 | -27.56% |
| May 29, 2024 | -29.41% |
| May 28, 2024 | -29.40% |
| May 24, 2024 | -32.20% |
| May 23, 2024 | -35.05% |
| May 22, 2024 | -33.45% |
| May 21, 2024 | -29.95% |
| May 20, 2024 | -31.26% |
| May 17, 2024 | -34.09% |
| May 16, 2024 | -27.01% |
| May 15, 2024 | -28.01% |
| May 14, 2024 | -26.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.10%
Minimum
Nov 17 2020
652.7%
Maximum
Jul 30 2019
-24.11%
Average
-40.46%
Median
Nov 07 2023
1 Year Total Returns (Daily) Benchmarks
| Trinity Biotech PLC | -43.05% |
| Cellectis SA | -13.87% |
| Akari Therapeutics PLC | 6.09% |
| Biodexa Pharmaceuticals Plc | -87.50% |
| Verona Pharma PLC | 11.68% |